AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
SOLIFENACIN SUCCINATE
63 registrations across 8 African markets— 57 active
Markets with SOLIFENACIN SUCCINATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Solifen 5 mg Tablets Film-Coated Tablet | 🇰🇪Kenya | Getz Pharma (Pvt) Limited | active | May 2031 |
| GOAB 5 Tablet | 🇷🇼Rwanda | HETERO DRUGS LIMITED | active | May 2031 |
| GOAB 10 Tablet | 🇰🇪Kenya | M/s. Hetero Labs Limited | active | Jul 2030 |
| GOAB 5 Tablet | 🇰🇪Kenya | M/s. Hetero Labs Limited | active | Jul 2030 |
| FENSIGLEN 10 mg | 🇿🇦South Africa | Glenmark Pharmaceuticals South Africa (Pty) Ltd | active | Sept 2029 |
| SOLIFENACIN 10 mg GLENMARK | 🇿🇦South Africa | Glenmark Pharmaceuticals South Africa (Pty) Ltd | active | Sept 2029 |
| SOLIFENACIN 5 mg GLENMARK | 🇿🇦South Africa | Glenmark Pharmaceuticals South Africa (Pty) Ltd | active | Sept 2029 |
| FENSIGLEN 5 mg | 🇿🇦South Africa | Glenmark Pharmaceuticals South Africa (Pty) Ltd | active | Sept 2029 |
| BLACIDEC 5 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MSN LABORATORIES PRIVATE LIMITED | active | Aug 2029 |
| BLACIDEC 10 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MSN LABORATORIES PRIVATE LIMITED | active | Aug 2029 |
| FIRSOLTAM | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Aug 2029 |
| GOAB 10 Tablets | 🇷🇼Rwanda | MS. ANNORA PHARMA PRIVATE LIMITED | active | Aug 2029 |
| SOLIFENACINS 10 ASCEND | 🇿🇦South Africa | Ascend Laboratories (Pty) Ltd | active | Jul 2029 |
| SOLIFENACINS 5 ASCEND | 🇿🇦South Africa | Ascend Laboratories (Pty) Ltd | active | Jul 2029 |
| GOAB 10 TABLET; ORAL | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Jun 2029 |
| GOAB 5 TABLET; ORAL | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Jun 2029 |
| GOAB 5 Tablets** Tablet | 🇳🇬Nigeria | Hetero Labs Nigeria Limited | active | Jan 2029 |
| GOAB 10 Tablets** Tablet | 🇳🇬Nigeria | Hetero Labs Nigeria Limited | active | Jan 2029 |
| Solifen Tablet 5 mg Tablet | 🇳🇬Nigeria | Getz Pharma Nigeria Limited | active | Dec 2028 |
| Solifen 10 mg Tablet Tablet | 🇳🇬Nigeria | Getz Pharma Nigeria Limited | active | Dec 2028 |
| Vesizen Tablets 5 mg Film coated tablet | 🇳🇬Nigeria | Ranbaxy Nigeria Limited | active | Oct 2028 |
| SOLUTRA-5 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD | active | Dec 2027 |
| BLACIDEC 10 Film-Coated Tablet | 🇰🇪Kenya | MSN Laboratories Private Limited | active | Dec 2027 |
| BLACIDEC 5 Tablet | 🇰🇪Kenya | MSN LABORATORIES PRIVATE LIMITED | active | Nov 2027 |
| URYSOREN-10 Tablet | 🇰🇪Kenya | Micro Labs Limited | active | Oct 2027 |
| URYSOREN-5mg Tablet | 🇰🇪Kenya | Micro Labs Limited | active | Oct 2027 |
| GOAB 5 TABLETS (Each film-coated tablet contains Solifenacin Succinate 5mg) | 🇬🇭Ghana | — | active | Nov 2026 |
| GOAB 5 TABLETS (Each film-coated tablet contains Solifenacin Succinate 5mg) | 🇬🇭Ghana | — | active | Nov 2026 |
| GOAB 10 TABLETS (Each film-coated tablet contains Solifenacin Succinate 10mg) | 🇬🇭Ghana | — | active | Nov 2026 |
| GOAB 10 TABLETS (Each film-coated tablet contains Solifenacin Succinate 10mg) | 🇬🇭Ghana | — | active | Nov 2026 |
| Vesizen 10 mg Tablets Tablet | 🇳🇬Nigeria | Ranbaxy Nigeria Limited | active | May 2026 |
| URYSOREN_10 10MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| URYSOREN_5 5MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| GOAB_10 10MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2024 |
| GOAB_5 5MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2024 |
| VESIZEN_5 5MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2023 |
| VESIZEN_10 10MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2023 |
| VESICARE 5 mg | 🇿🇦South Africa | Astellas Pharma (Pty) Ltd | active | Jan 1900 |
| SOLIREST 10 mg | 🇿🇦South Africa | iPharma (Pty) Ltd | active | Jan 1900 |
| VESICARE 10 mg | 🇿🇦South Africa | Astellas Pharma (Pty) Ltd | active | Jan 1900 |
| FURLIN 5 | 🇿🇦South Africa | Trinity Pharma (Pty) Ltd | active | Jan 1900 |
| SOLIREST 5 mg | 🇿🇦South Africa | iPharma (Pty) Ltd | active | Jan 1900 |
| VESINORM 10 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Jan 1900 |
| TRUNACE 5 | 🇿🇦South Africa | Trinity Pharma (Pty) Ltd | active | Jan 1900 |
| TRUNACE 10 | 🇿🇦South Africa | Trinity Pharma (Pty) Ltd | active | Jan 1900 |
| BULAPT 5 | 🇿🇦South Africa | Trinity Pharma (Pty) Ltd | active | Jan 1900 |
| BULAPT 10 | 🇿🇦South Africa | Trinity Pharma (Pty) Ltd | active | Jan 1900 |
| ENIRLAD 5 | 🇿🇦South Africa | Trinity Pharma (Pty) Ltd | active | Jan 1900 |
| ENIRLAD 10 | 🇿🇦South Africa | Trinity Pharma (Pty) Ltd | active | Jan 1900 |
| FURLIN 10 | 🇿🇦South Africa | Trinity Pharma (Pty) Ltd | active | Jan 1900 |
Showing 50 of 63 registrations. Sign up free to search and export all.
SOLIFENACIN SUCCINATE in Africa — Regulatory Overview
SOLIFENACIN SUCCINATE is registered across 8 African markets with 63 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Uganda, Kenya, Malawi and 4 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 63 registrations, 57 (90%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.